2019Q4 and 2019K Any thoughts of how the following two items will impact 2019Q4 and 2019K reporting?
1. Beginning with the fourth quarter, the Company is planning on presenting all adjustments as reductions of revenue instead of presenting both revenue reductions and bad debt expense to better align with other healthcare providers. The mid-point of the revenue guidance represents a 35% increase over the quarter ended December 31, 2018.
2. Conversion of Accounts Payable into Short-term Capital Lease
Subsequent to September 30, 2019, the Company entered into a capital lease agreement with a third party and, as a result, $1,219,000 of accounts payable was converted to a two year lease.
Also, Viemed states in their Investor presentation: "Viemed is the largest independent specialized provider of non-invasive ventilation (NIV) in the US home respiratory health care industry"
They go on to state: "NIV MARKET PENETRATION: Viemed third largest provider at 10%"
Who are the largest and second largest providers?